IN APPLICABILITY OF THE CARDIOVASCULAR RISK PREDICTOR "SCORE" TO PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH) by Descamps, O, Cooper, J, Neil, A, Humphries, S, Committee, S

Pooled safety analysis of evolocumab in over 6000 patients from double-blind and open-label extension studies by Toth, P, Descamps, O, Genest, J, Sattar, N, Preiss, D, Dent, R, Djedjos, C, Wu, Y, Geller, M, Uhart, M, Somaratne, R, Wasserman, S, for the PROFICIO Investigators

Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. by Talmud, P, Shah, S, Whittall, R, Futema, M, Howard, P, Cooper, J, Harrison, S, Li, K, Drenos, F, Karpe, F, Neil, H, Descamps, O, Langenberg, C, Lench, N, Kivimaki, M, Whittaker, J, Hingorani, A, Kumari, M, Humphries, SE

Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations. by Futema, M, Plagnol, V, Li, K, Whittall, R, Neil, H, Seed, M, Bertolini, S, Calandra, S, Descamps, O, Graham, C, Hegele, R, Karpe, F, Durst, R, Leitersdorf, E, Lench, N, Nair, DR, Soran, H, Van Bockxmeer, F, Humphries, SE

Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: A case-control study by Talmud, P, Shah, S, Whittall, R, Futema, M, Howard, P, Cooper, J, Harrison, S, Li, K, Drenos, F, Karpe, F, W Neil, H, Descamps, O, Langenberg, C, Langenberg, C, Lench, N, Kivimaki, M, Whittaker, J, Whittaker, J, Hingorani, A, Kumari, M, Humphries, SE, Humphries, SE